Publications

1.Antifungal Combinations for Treatment of Cryptococcal Meningitis in Africa
Molloy SF, Kanyama C, Heyderman RS, Loyse A, Kouanfack C, Chanda D, Mfinanga S, Temfack E, Lakhi S, Lesikari S, Chan AK, Stone N, et al…
The New England Journal of Medicine. March 2018; 378:1004-1017
DOI: 10.1056/NEJMoa1710922

2.Timing of Antiretroviral Therapy After Diagnosis of Cryptococcal Meningitis
Boulware DR, Meya DB, Muzoora C, Rolfes MA, Hullsiek KH, Musubire A, Taseera K, Nabeta HW, Schutz C, Williams DA, Rajasingham R, Rhein J, Thienemann F, Lo MW, Nielsen K, Bergemann TL, Kambugu A, Manabe YC, Janoff EN, Bohjanen PR, Meintjes G, for the COAT Trial Team*
The New England Journal of Medicine. June 2014; 370:2487-2498
DOI: 10.1056/NEJMoa1312884

3.HIV-associated Cryptococcal Meningitis : Bridging the Gap Between Developed and Resource-Limited Settings
Tenforde MW, Wake R, Leeme T, Jarvis JN.
Current Clinical Microbiology Reports. March 2016; 3:92-102. PMCID:PMC4845086 [Free PMC Article]

4.Neurological Sequelae of Adult Meningitis in Africa : A Systematic Literature Review
Drew W Goldberg, Mark W Tenforde, Hannah K Mitchell, Joseph N Jarvis.
Open Forum Infectious Diseases. November 2017; Volume 5, Issue 1.
PMCID: PMC5753229 [Free PMC Article]

5.Cryptococcal Meningitis : Epidemiology, Immunology, Diagnosis and Therapy
Williamson PR, Jarvis JN, Panackal AA, Fisher MC, Molloy SF, Loyse A, Harrison TS. Nature Reviews Neurology. 2017 Jan;13(1):13-24. doi: 10.1038/nrneurol.2016.167. Epub 2016 Nov 25.

6.Prediction of Outcome From Adult Bacterial Meningitis in a High-HIV-Seroprevalence, Resource-Poor Setting Using The Malawi Adult Meningitis Score (MAMS)
Wall EC, Mukaka M, Scarborough M, Ajdukiewicz KMA, Cartwright KE, Nyirenda M, Denis B, Allain TJ, Faragher B, Lalloo DG, Heyderman RS.
Clinical Infectious Diseases. February 2017; Volume 64, Issue 4: Pages 413-419.PMCID:PMC5399948 [Free PMC Article]

7.Bacterial Meningitis in Malawian Adults, Adolescents and Children During the Era of Antiretroviral Scale-Up and Haemophilus Influenzae Type B Vaccination
Wall EC, Everett DB, Mukaka M, Bar-Zeev N, Feasey N, Jahn A, Moore M, van Oosterhout JJ, Pensalo P, Baguimira K, Gordon SB, Molyneux EM, Carrol ED, French N, Molyneux ME, Heyderman RS.
Clinical Infectious Diseases. May 2014; Volume 58, Issue 10: e137-45

8.Management of Amphotericin-induced Phlebitis Among HIV Patients With Cryptococcal Meningitis in a Resource-limited Setting: A Prospective Cohort Study 
Ahimbisibwe C, Kwizera R, Ndyetukira JF, Kugonza F, Sadiq A, Huppler-Hullsiek K, Williams DA, Rhein J, Boulware DR, Meya DB. BioMed Central (BMC) Infectious Diseases. Volume 19, Article number: 558 (2019)

9.The Conundrum of Clinical Trials and Standard of Care in Sub-Saharan Africa – The Research Nurse Perspective
Ndyetukira JF,  R, Kugonza F, Ahimbisibwe C, Namujju C, Sadiq A, Namudde A, Williams D, Abassi M, Rhein J, Boulware DR, Meya DB. Journal of Research in Nursing. March 2019. DOI: 10.1177/1744987118824625

10.Intensified Antibiotic Treatment of Tuberculosis Meningitis
Cresswell FV, Brake LT, Atherton R, Ruslamid R, Dooleye KE, Aarnoutse R, Van Crevel R. Expert Review of Clinical Pharmacology, 12:3, 267-288,
DOI: 10.1080/17512433.2019.1552831

11.High Mortality in HIV-associated Cryptococcal Meningitis Patients Treated with Amphotericin B-based Therapy Under Routine Care Conditions in Africa
Patel RKK, Leeme T, Azzo C, Tlhako N, Tsholo K, Tawanana EO, Molefi M, Mosepele M, Lawrence DS, Mokomane M, Tenforde MW, Jarvis JN.
Open Forum Infectious Diseases. 2018 Nov; 5(11): ofy267. Published online 2018 Oct 23. DOI: 10.1093/ofid/ofy267. PMCID: PMC6251350

12.Epidemiology of Adult Meningitis During Antiretroviral Therapy Scale-up in Southern Africa: Results from the Botswana National Meningitis Survey
Tenforde MW, Mokomane M, Leeme T, Tlhako N, Tsholo K, Ramodimoosi C, Dube B, Mokobela KO, Tawanana E, Chebani T, Pilatwe T, Hurt WJ, Mitchell HK, Molefi M, Mullan PC, Guthrie BL, Farquhar C, Steenhoff AP, Mine M, Jarvis JN.
Journal of Infection. 2019 Sep; 79(3): 212–219. Published online 2019 Jun 28. DOI: 10.1016/j.jinf.2019.06.013. PMCID: PMC6679721. Currently embargoed: Free in PMC on Sep 1, 2020; PubMed

13.Global Burden of Disease of HIV-Associated Cryptococcal Meningitis : An Updated Analysis
Rajasingham R, Smith RM, Park BJ, Jarvis JN, Govender NP, Chiller TM, et al.
The Lancet Infectious Diseases. 2017 Aug;17(8):873-881.
DOI: 10.1016/S1473-3099(17)30243-8. Epub 2017 May 5.

14.Impact of Routine Cryptococcal Antigen Screening and Targeted Preemptive Fluconazole Theorapy In Antiretroviral-Naive Human Immunodeficiency Virus-Infected Adults With CD4 Cell Counts <100/μL : A Systematic Review and Meta Analysis
Temfack E, Bigna JJ, Luma HN, Spijker R, Meintjes G, Jarvis JN, Dromer F, Harrison T, Cohen JF, Lortholary O.
Clinical Infectious Diseases, Volume 68, Issue 4, 15 February 2019, Pages 688–698, https://doi.org/10.1093/cid/ciy567

15.Understanding Causal Pathways in Cryptococcal Meningitis Immune Reconstitution Inflammatory Syndrome
Jarvis JN, Harrison TS.
The Journal of Infectious Diseases. 2019 Jan 9;219(3):344-346. DOI: 10.1093/infdis/jiy448.

16.High Cryptococcal Antigen Titers in Blood Are Predictive of Subclinical Cryptococcal Meningitis Among Human Immunodeficiency Virus-Infected Patients
Wake RM, Britz E, Sriruttan C, Rukasha I, Omar T, Spencer DC, Nel JS, Mashamaite S, Adelekan A, Chiller TM, Jarvis JN, Harrison TS, Govender NP.
Clinical Infectious Diseases. Volume 66, Issue 5, 1 March 2018, Pages 686–692, https://doi.org/10.1093/cid/cix872

 17.Advanced Human Immunodeficiency Virus Disease in Botswana Following Successful Antiretroviral Therapy Rollout: Incidence of and Temporal Trends in Cryptococcal Meningitis.
Tenforde MW, Mokomane M, Leeme T, Patel RKK, Lekwape N, Ramodimoosi C, Dube B, Williams EA, Mokobela KO, Tawanana E, Pilatwe T, Hurt WJ, Mitchell H4, Banda DL, Stone H, Molefi M, Mokgacha K, Phillips H12, Mullan PC, Steenhoff AP, Mashalla Y, Mine M, Jarvis JN
Clinical Infectious Diseases. 2017 Sep 1;65(5):779-786. DOI: 10.1093/cid/cix430.

18.The Changing Epidemiology of HIV-Associated Adult Meningitis, Uganda 2015–2017
Ellis J, Bangdiwala AS, Cresswell FV, Rhein JNuwagira E Ssebambulidde KTugume L, Rajasingham RBridge SCMuzoora C, Meya DB, Boulware DR, on behalf of the ASTRO-CM Team
Open Forum Infectious Diseases, Volume 6, Issue 10, October 2019, ofz419, https://doi.org/10.1093/ofid/ofz419